Education
About Us
Working with TipRanks
Follow Us
Robert L Ferrara Insider Profile
4 Followers
Robert L Ferrara, Director at Phio Pharmaceuticals, holds 15.67K shares in Phio Pharmaceuticals (Ticker: PHIO). Most recently, Robert L Ferrara Bought $2,500 shares of Phio Pharmaceuticals on Jun 11, 2025 for an estimated value of 6.03K.
Robert L Ferrara Phio Pharmaceuticals (PHIO)Director
Phio Pharmaceuticals (PHIO)
Director
Ranked #95,796 out of 102,596 Corporate Insiders
Profitable Transactions
1 out of 6 Profitable Transactions
Average Return
-45.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Robert L Ferrara's holdings
Insider Roles
Director
Roles that Robert L Ferrara holds in companies
Most Profitable Insider Trade
The most profitable trade made by Robert L Ferrara
Robert L Ferrara's Trading History
List of latest transactions for each holding click on a transaction to see Robert L Ferrara's performance on stock
You May Also Like
Robert L Ferrara insider profile FAQ
What is the percentage of profitable transactions made by Robert L Ferrara?
The percentage of profitable transactions made by Robert L Ferrara is 17%.
What is the average return per transaction made by Robert L Ferrara?
The average return per transaction made by Robert L Ferrara is -45.20%.
What stocks does Robert L Ferrara hold?
Robert L Ferrara holds: PHIO stocks.
What was Robert L Ferrara’s latest transaction?
Robert L Ferrara latest transaction was an Informative Buy of $6.03K.
What was Robert L Ferrara's most profitable transaction?
Robert L Ferrara’s most profitable transaction was an Informative Buy of PHIO stock on May 21, 2025. The return on the trade was 36.80%.
What is Robert L Ferrara's role in Phio Pharmaceuticals?
Robert L Ferrara's role in Phio Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.